ICYMI: Biogen Says the Company is Pulling Back on Selling Its Alzheimer's Drug Aduhelm ... - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'ICYMI: Biogen says the company is pulling back on selling its Alzheimer's drug Aduhelm after the U.S. government’s Medicare program restricted coverage of the controversial treatment to patients in clinical trials ...'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)